Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis

Gastrointestinal Endoscopy

Volumn 56, Issue 6, 2002, Pages 885-889

  Rerknimitr, Rungsun ^a   Fogel, Evan L ^a,b   Kalayci, Cem ^a   Esber, Edward ^a   Lehman, Glen A ^a   Sherman, Stuart ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BILE DUCT OBSTRUCTION; BILE DUCT PROSTHESIS; CHILD; CHOLANGITIS; CHOLESTASIS; COMMON BILE DUCT STONE; CONTROLLED STUDY; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; ENDOPROSTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; PRIORITY JOURNAL; SEPSIS; STENT; TREATMENT PLANNING;

EID: 0037001095     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(02)70365-9     Document Type: Article

References (21)

1. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs 1999;57:81-91.
2. Niederau C, Pohlmann U, Lubke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 1994;40:533-7.
3. Byl B, Deviere J, Struelens MJ, Roucloux I, De Connick A, Thys JP, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized double-blind, placebo-controlled study. Clin Infect Dis 1995;20:1236-40.
4. Delikaris PG, Michail PO, Klonis GD, Haritopoulos NC, Golematis BC, Dreiling DA. Biliary bacteriology based on intraoperative bile culture. Am J Gastroenterol 1977;68:51-5.
5. Mason GR. Bacteriology and antibiotic selection in biliary tract surgery. Arch Surg 1968;97:533-7.
6. Wilcox MH, Rice P. Spencer RC. Biliary stent associated infection. J Hosp Infect 1991;18:82-4.
7. Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprosthesis. A morphologic and bacteriologic study. Scand J Gastroenterol 1991;26:1137-44.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing approved standard M2-A4. Villanova (PA): National Committee for Clinical Laboratory Standards; 1997.
9. Reisner BS, Woods GL, Thomson RB, Larone DH, Garcia LS, Shimizu RY. Specimen processing. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington, DC: ASM Press; 1998. p. 85-9.
10. Sung JY, Leung JW, Shaffer EA, Lam K, Olson ME, Costerton JW. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 1992;7:240-5.
11. Leung JW, Liu YL, Desta T, Libby E, Inciardi JF, Lam K. Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents? Gastrointest Endosc 1998;48:250-7.
12. Lorenz R, Herrmann M, Kassem AM, Lehn N, Neuhaus H, Classen M. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system. Endoscopy 1998;30:708-12.
13. Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994;40:716-21.
14. Van den Hazel SJ, De Vries XH, Speelman P, Dankert J, Tytgat GN, Huibregtse K, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996;40:2658-60.
15. Lettieri JT, Rogge MC, Kaiser L, Echols RM, Heller AH. Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 1992;36:993-6.
16. Shah A, Lettieri J, Kaiser L, Echols R, Heller AH. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. J Antimicrob Chemother 1994;33:795-801.
17. Wurbs DFW, Sivak MV Jr. Calculus disease of the bile ducts. In: Sivak MV Jr, editor. Gastroenterologic endoscopy. 2nd ed. Vol. 2. Philadelphia: WB Saunders; 2000. p. 923-47.
18. ASGE. Preparation of patients for gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1998;48:691-4.
19. Bilhartz LE, Horton JD. Gallstone disease and its complications. In: Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. 6th ed. Philadelphia: WB Saunders. 1998. p. 948-72.
20. Patel SA, Borges MC, Batt MD, Rosenblate HJ. Trichosporon cholangitis associated with hyperbilirubinemia, and findings suggesting primary sclerosing cholangitis on endoscopic retrograde cholangiopancreatography. Am J Gastroenterol 1990;85:84-7.
21. Ojeas H, Hu HC, Greenberg SB. Candidemia after endoscopic retrograde cholangiopancreatography, South Med J 1995;88:465-6.